events rule
SYN's Irritable Bowel Syndrome (IBS) Investor Day
Tuesday, September 16, 2014
9:00am - 11:00am EDT

Synthetic Biologics' CEO, Jeffery Riley, will provide an overview of the anticipated clinical and regulatory pathway for SYN-010 to reduce the impact of methane producing organisms on C-IBS, including plans to file an Investigational New Drug (IND) application and initiate a Phase II dose-discovery and proof-of-mechanism clinical study in the second half of 2014. Keynote speaker, Mark Pimentel, M.D., FRCP(C), Director, GI Motility Program and Laboratory, Cedars-Sinai Medical Center and Chairman, Synthetic Biologics' C-IBS Clinical Advisory Board, will discuss his groundbreaking work that led to the discovery of SYN-010, including the association between the overproduction of methane gas by microorganisms in the gut and conditions such as C-IBS, as well as further detail for SYN-010 itself.

Interested parties may log in to the live webcast over the Internet at SYN IBS Investor Day Webcast.

Phase II TrimestaTM for Multiple Sclerosis Conference Call
Friday, September 12, 2014
9:15am EDT

Synthetic Biologics will host a an investor conference call on Friday, September 12, 2014, at 9:15 a.m. EDT. The conference call will highlight TrimestaTM, the Company’s oral product candidate for the treatment of relapsing-remitting multiple sclerosis (MS), immediately following the oral presentation at 8:39 a.m. EDT by lead academic investigator, Rhonda Voskuhl, M.D., at the 2014 Joint Americas and European Committees for Treatment and Research in Multiple Sclerosis Meeting (ACTRIMS-ECTRIMS) in Boston.

Interested parties should call 1-877-870-4263 (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1 412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast live over the Internet at http://www.videonewswire.com/event.asp?id=100450.

Aegis Capital Corp. 2014 Healthcare & Technology Conference
Thursday, September 11, 2014
10:00am - 10:25am PDT

Jeffrey Riley, CEO, is scheduled to present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference. Mr. Riley is scheduled to present at 10:00 a.m. (Pacific Time) on Thursday, September 11, 2014 at The Encore at Wynn, Las Vegas. No webcast is available.

16th Annual Rodman & Renshaw Global Investment Conference
Tuesday, September 9, 2014
10:25am - 10:50am EDT

Jeffrey Riley, CEO, is scheduled to present at the 16th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. Mr. Riley is scheduled to present at 10:25 a.m. (Eastern Time) on Tuesday, September 9, 2014 at the New York Palace Hotel in New York City.

A live webcast of Synthetic Biologics’ presentation may be accessed by logging onto the internet at http://wsw.com/webcast/rrshq24/syn.

ICAAC: Rational Design of Antibody Cocktails to Treat Disease Caused by Bordetellae
Sunday, September 7, 2014
9:45am EDT

Synthetic Biologics' academic collaborator, Jennifer Maynard, Ph.D., of The University of Texas at Austin's McKetta Department of Chemical Engineering will present Synthetic Biologics' SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 5-9, in Washington D.C. Dr. Maynard's oral presentation is scheduled for Sunday, September 7, at 9:45am Eastern Time in Room 209A as part of the "Neonatal Infections and the Case for Maternal Immunization" session.

ICAAC: P4A, a Novel Oral Beta-Lactamase for the Prevention of Cephalosporin-Induced C. difficile Infection
Saturday, September 6, 2014
12:00pm - 2:00pm EDT

Synthetic Biologics' Senior Vice President, Research & Development, Mike Kaleko, M.D., Ph.D., will present a late-breaking poster (Poster: F-250c) related to the Company's C. difficile program at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 5-9, in Washington D.C. The poster will be available for viewing in Exhibit Hall A on Saturday, September 6, from 12:00pm to 2:00pm Eastern Time, as part of the "Agents Targeting Clostridium difficile" session.

 

Second Quarter 2014 Investor Conference Call
Thursday, August 14, 2014
8:30am EDT

Synthetic Biologics, Inc. will hold an investor conference call on Thursday, August 14, at 8:30 am EDT. Interested parties should call 1-877-870-4263 (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1 412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet at http://www.videonewswire.com/event.asp?id=100224. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=100224, for 30 days after the call.

2014 Annual Meeting of Stockholders
Tuesday, June 10, 2014
9:00am EDT

The 2014 Annual Meeting of Stockholders of Synthetic Biologics, Inc., a Nevada corporation, will be held on June 10, 2014 at 9:00 a.m. (Eastern time), at the New York City office of Gracin & Marlow, LLP, Chrysler Building, 405 Lexington Avenue, 26 th  Floor, New York, New York, 10174.

Asia Biotech Invest 2014
Thursday, June 5, 2014
12:00pm HKT

Evan Ballantyne, Synthetic Biologics' CFO, is scheduled to present at Asia Biotech Invest 2014 to be held on June 4-5, 2014 in Hong Kong. Mr. Ballantyne is scheduled to present at Noon (Hong Kong Time) Wednesday, June 5, 2014 at the Sheraton Hong Kong.

Webcasting is not available at this event.

Marcum LLP MicroCap Conference
Thursday, May 29, 2014
4:30pm EDT

Jeff Riley, Synthetic Biologics' CEO, is scheduled to present on Thursday, May 29, 2014 at 4:30pm (ET).

A live webcast of Synthetic Biologics' presentation can be accessed by logging onto the web at http://wsw.com/webcast/marcum2/syn . After the presentation, a replay will be archived and accessible for 60 days at the same website.

BioEquity Europe 2014
Thursday, May 22, 2014
3:00pm - 3:20pm CEST

Jeff Riley, Synthetic Biologics' CEO, will present at BioEquity Europe 2014 to be held on May 21-22, 2014 in Amsterdam, Netherlands. Mr. Riley is scheduled to present at 3:00 p.m. (Central European Summer Time) Thursday, May 22, 2014 at the Hilton Amsterdam Hotel.

Webcasting is not available at this event.

First Quarter 2014 Investor Conference Call
Thursday, May 15, 2014
8:30am EDT

Synthetic Biologics, Inc. will hold an investor conference call on Thursday, May 15, 2014, at 8:30 am EDT. Interested parties should call 1-877-870-4263 (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1 412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet at http://www.videonewswire.com/event.asp?id=99332. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=99332, for 30 days after the call.

Synthetic Biologics, Inc. Trimesta Phase II Data Discussion
Wednesday, April 30, 2014
9:00am EDT

Jeffrey Riley, Chief Executive Officer, and Joe Sliman, Senior Vice President, Clinical & Regulatory Affairs, of Synthetic Biologics, Inc. will host a conference call to discuss in further detail the topline Phase II study results of TrimestaTM (oral estriol).

Interested parties should call 1-877-870-4263, (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1-412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet with a slide presentation at http://www.videonewswire.com/event.asp?id=99175. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=99175 for 60 days after the call.

American Academy of Neurology - Rhonda Voskuhl, M.D. - Topline Phase II Trimesta Results for Relapsing-Remitting MS
Tuesday, April 29, 2014 - Wednesday, April 30, 2014

Rhonda Voskuhl, M.D., the lead investigator of the Phase II clinical trial evaluating the Company's oral estriol product candidate, Trimesta™, for the treatment of relapsing-remitting multiple sclerosis (MS), will present topline results at the American Academy of Neurology's (AAN) 66th Annual Meeting in Philadelphia. The abstract titled, A Combination Trial of Estriol Plus Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis, will be presented as part of the AAN Emerging Science program during two sessions, as follows:

MS and CNS Inflammatory Disease: Novel Therapeutics
Presentation: 003
Event Date: Tuesday, April 29, 2014
Presentation Time: 3:45 p.m. (ET)

Emerging Therapeutic Advances in Multiple Sclerosis
Presentation: 002
Event Date: Wednesday, April 30, 2014
Presentation Time: 5:35 p.m. (ET)

No webcast available.

Year End 2013 Investor Conference Call
Monday, March 31, 2014
10:00am EDT

Synthetic Biologics will hold an investor conference call on Monday, March 31, 2014, at 10:00 am EDT. Interested parties should call 1-877-870-4263 (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1 412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet at http://www.videonewswire.com/event.asp?id=98657. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=98657 for 30 days after the call.

26th Annual ROTH Conference
Tuesday, March 11, 2014
2:00pm PDT

Jeffrey Riley, Synthetic Biologics' CEO, is scheduled to present on Tuesday, March 11, 2014 at 2:00 p.m. (Pacific Time).

A live webcast of Synthetic Biologics' presentation can be accessed by logging onto the web at http://wsw.com/webcast/roth28/SYN. After the presentation, a replay will be archived and accessible for 30 days at the same website.

BIO CEO & Investor Conference 2014
Monday, February 10, 2014
10:00am EST

Jeffrey Riley, CEO, is scheduled to present at the BIO CEO & Investor Conference on Monday, February 10, 2014, at 10:00 a.m. (ET) in the Duke of Windsor room at the Waldorf Astoria in New York.

A live webcast of Synthetic Biologics' presentation may be accessed by logging onto the internet at http://www.veracast.com/webcasts/bio/ceoinvestor2014/98124275805.cfm. After the presentation, a replay will be archived and accessible for 30 days at the same website.

Biotech Showcase 2014 Conference
Wednesday, January 15, 2014
9:30am PST

Jeffrey Riley, CEO, will present at the Biotech Showcase 2014 Conference at 9:30 a.m. (PT) on Wednesday, January 15, 2014 in the Mission II Room at the Parc 55 Wyndham in San Francisco-Union Square.

A live webcast of Synthetic Biologics' presentation may be accessed by logging onto the internet at http://www.media-server.com/m/p/5hizpa44. After the presentation, a replay will be archived and accessible for 30 days at the same website.

OneMedForum San Francisco 2014 Conference
Tuesday, January 14, 2014
11:30am PST

Jeff Riley, Synthetic Biologics' CEO, will present at the OneMedForum San Francisco 2014 Conference being held at the Westin San Francisco on January 14, 2014.

A live webcast of Synthetic Biologics’ presentation will be available. URL: http://onemedplace.com/forum/webcast/. After the presentation, the archived replay will be available via OneMed Fourm at same same URL.

Archaea-Associated Diseases Conference Call with Mark Pimentel, MD, of Cedars-Sinai Medical Center
Monday, December 9, 2013
9:00am EST

Synthetic Biologics' Chief Executive Officer, Jeffrey Riley, will host a conference call on Monday, December 9th at 9:00 a.m. EST. During the call, Mark Pimentel, M.D., FRCP©, Director of the Gastrointestinal Motility Program at Cedars-Sinai, will provide an audio-visual presentation overview of the scientific basis and market opportunity of our new pathogen-specific approaches to archaea-associated diseases, such as, C-IBS, obesity and diabetes.

Interested parties should call 1-877-870-4263, (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1-412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet with a slide presentation at http://www.videonewswire.com/event.asp?id=97322.

If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=97322.

2013 Therapeutic Area Partnerships Conference
Tuesday, November 19, 2013
4:00pm EST

SYN-004, Synthetic Biologics' product candidate for the prevention of C. difficile infections, was selected as a 2013 Top Project to Watch in the infectious disease area by Elsevier Business Intelligence.

Jeffrey Riley, CEO, will present at the 2013 Therapeutic Area Partnerships Conference on Tuesday, November 19, 2013 at 4:00pm (EST) at the Hyatt Regency in Boston.

Please note, this conference does not provide webcasting.

BIO-Europe 2013
Monday, November 4, 2013 - Wednesday, November 6, 2013

Synthetic Biologics' management will be participating at BIO-Europe 2013 in Vienna, Austria.
 

BioJapan 2013 World Business Forum
Wednesday, October 9, 2013
11:25am - 11:40am JST

Jeff Riley, Synthetic Biologics' CEO, will present at the BioJapan 2013 World Business Forum being held on October 9-11, 2013 in Yokohama, Japan. Mr. Riley is scheduled to present at 11:25 a.m. (Japan Standard Time) on Wednesday, October 9, 2013 at Pacifico Yokohama.

Webcasting is not available for this event.

First Global Life Sciences Conference - Warsaw, Poland
Monday, September 16, 2013
5:15am EDT

Jeff Riley, Synthetic Biologics' CEO, will present at the First Global Life Sciences Conference to be held on September 16-17, 2013 in Warsaw, Poland. Mr. Riley is scheduled to present at 11:15 a.m. (Central European Summer Time)/5:15 a.m. (Eastern Time) on Monday, September 16, 2013 at the Warsaw Stock Exchange.

A live webcast of Synthetic Biologics’ presentation will be available. URL: http://www.wdmcapital.com/en/strony/lsc/live_webcast.html

After the presentation, the archived replay will be available via at the following URL:http://www.wdmcapital.com/en/strony/lsc/live_webcast.html

Rodman & Renshaw 15th Annual Healthcare Conference
Monday, September 9, 2013
12:05pm EDT

Jeff Riley, Synthetic Biologics' CEO, will present at the Rodman & Renshaw 15th Annual Healthcare Conference being held at the Millennium Broadway Hotel in New York City on September 9, 2013.

A live webcast of Synthetic Biologics’ presentation will be available. URL: http://wsw.com/webcast/rrshq23/SYN

After the presentation, the archived replay will be available via at the following URL: http://wsw.com/webcast/rrshq23/SYN